Hikma Resumes Launch Of Advair Rival

Follows FDA Approval Of ANDA Amendment That Forced Pause

Restart Wooden Blocks
Hikma has restarted launch activities for its generic version of Advair • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin